A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Cancer stem cells that survive after a tumor is treated go on to form new tumors that do not respond to further treatment.

A study from Lund University identifies foam cells in glioblastoma patients, revealing their role in promoting tumor growth.

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced an update on its ...

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

Trevor Reese is 26 years old and is battling Glioblastoma brain cancer. Reese and his family learned about ... The treatment ...

Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, ...

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the ...

Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals , formed to develop transformative CNS cancer treatments with AI-powered innovation, announced today the formation of a ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

Your local merchants are the same ones who support your local sports teams, fundraisers and church events, along with paying ...